Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss
/O/ 3rd time's a charm?
16 views
Skip to first unread message
⁹⁹⁹√ulcаn
Dec 8, 2021, 12:37:16 PM12/8/21
to
"The coronavirus vaccine developed jointly by BioNTech and Pfizer is
“still effective” against the Omicron variant of the virus after three
doses, the two companies said on Wednesday.
An Omicron-specific version of the jab, which BioNTech began developing
on November 25, will be available “by March,” they said in a statement.
Pfizer said that a third dose of its COVID vaccine “increases the
neutralizing antibody titers by 25-fold compared to two doses against
the Omicron variant,” based on an initial laboratory study.
The initial data, said Pfizer, shows that “a third dose provides a
similar level of neutralizing antibodies to Omicron as is observed after
two doses against” previous strains of COVID-19."
https://www.timesofisrael.com/pfizer-says-three-doses-of-its-covid-vaccine-protect-against-omicron/
“still effective” against the Omicron variant of the virus after three
doses, the two companies said on Wednesday.
An Omicron-specific version of the jab, which BioNTech began developing
on November 25, will be available “by March,” they said in a statement.
Pfizer said that a third dose of its COVID vaccine “increases the
neutralizing antibody titers by 25-fold compared to two doses against
the Omicron variant,” based on an initial laboratory study.
The initial data, said Pfizer, shows that “a third dose provides a
similar level of neutralizing antibodies to Omicron as is observed after
two doses against” previous strains of COVID-19."
https://www.timesofisrael.com/pfizer-says-three-doses-of-its-covid-vaccine-protect-against-omicron/
Const
Dec 8, 2021, 1:11:03 PM12/8/21
to
???√ulcаn <99...@russian.z1> wrote:
> "The coronavirus vaccine developed jointly by BioNTech and Pfizer is
> ?still effective? against the Omicron variant of the virus after three
> "The coronavirus vaccine developed jointly by BioNTech and Pfizer is
> doses, the two companies said on Wednesday.
> An Omicron-specific version of the jab, which BioNTech began developing
> on November 25, will be available ?by March,? they said in a statement.
> An Omicron-specific version of the jab, which BioNTech began developing
> Pfizer said that a third dose of its COVID vaccine ?increases the
> neutralizing antibody titers by 25-fold compared to two doses against
> the Omicron variant,? based on an initial laboratory study.
> The initial data, said Pfizer, shows that ?a third dose provides a
> similar level of neutralizing antibodies to Omicron as is observed after
> two doses against? previous strains of COVID-19."
> https://www.timesofisrael.com/pfizer-says-three-doses-of-its-covid-vaccine-protect-against-omicron/
Чета сомнения есть.
https://www.ahri.org/omicron-incompletely-escapes-immunity-induced-by-the-pfizer-vaccine/
---
Const
⁹⁹⁹√ulcаn
Dec 8, 2021, 1:35:37 PM12/8/21
to
https://groups.google.com/g/alt.russian.z1/c/u9u08jeqXLM/m/h8j4W-m9BgAJ
и эта тема освещена в ToI статье по моей ссылке вверху:
Initial research from a South Africa-based laboratory indicated that the
efficacy of two doses of the Pfizer vaccine drops in the face of the
Omicron variant, but that those with two doses plus a previous infection
were well protected.
There were no participants included in the study who had received three
doses of the vaccine, since booster shots are not yet available in South
Africa.
⁹⁹⁹√ulcаn
Dec 8, 2021, 2:18:41 PM12/8/21
to
On 12/8/2021 1:35 PM, ⁹⁹⁹√ulcаn wrote:
> и эта тема освещена в ToI статье по моей ссылке вверху:
>
> Initial research from a South Africa-based laboratory indicated that the
> efficacy of two doses of the Pfizer vaccine drops in the face of the
> Omicron variant, but that those with two doses plus a previous infection
> were well protected.
>
> There were no participants included in the study who had received three
> doses of the vaccine, since booster shots are not yet available in South
> Africa.
It’s a Third Dose Against Omicron, not a Booster, BioNTech CEO Says
> и эта тема освещена в ToI статье по моей ссылке вверху:
>
> Initial research from a South Africa-based laboratory indicated that the
> efficacy of two doses of the Pfizer vaccine drops in the face of the
> Omicron variant, but that those with two doses plus a previous infection
> were well protected.
>
> There were no participants included in the study who had received three
> doses of the vaccine, since booster shots are not yet available in South
> Africa.
https://www.barrons.com/articles/covid-omicron-biontech-pfizer-51638988700
The antibody responses seen in lab tests conducting using the blood
samples suggest that three doses of the original vaccine provides as
much protection against infection caused by Omicron as two doses against
the original strain of the virus.
Two doses of the vaccine, meanwhile, appear to provide little protection
against infection by Omicron, though the companies said that they expect
that other immune mechanisms would provide protection against
hospitalization and death.
That implies substantial changes may be required to global vaccination
plans. BioNTech CEO Dr. Ugur Sahin said at a virtual press conference on
Wednesday that, against Omicron, the vaccine is effectively a three-dose
vaccine.
“It is very clear, our vaccine, for the Omicron variant, should be a
three-dose vaccine,” Sahin said.
dp
Dec 8, 2021, 8:10:41 PM12/8/21
to
⁹⁹⁹√ulcаn
Dec 8, 2021, 9:00:01 PM12/8/21
to
media
Dec 11, 2021, 4:32:34 PM12/11/21
to
0 new messages